CYCC Wutah pendapatan triwulanan Cyclacel Pharmaceuticals

Simbol lan logo merek Cyclacel, Inc. (CYCC)

Cyclacel Pharmaceuticals (CYCC) attracts researchers with its freedom in small molecule development and an ethical corporate culture. The biotech company develops cell cycle control agents to combat solid tumors in the UK and the US. The quarterly change in sales volume demonstrates revenue dynamics, while -99.50 captures a new level mark. The business is currently actively developing its line of inhibitors as part of clinical trials.

Cyclacel, Inc. (CYCC) - Tingkat wutah pendapatan sajrone kuartal saka 04.07.2022 nganti 12.09.2025

Cyclacel (CYCC) - rincian metrik lan laporan keuangan

- data dhuwit lan arus kas:
Analisis umum perusahaan:Cyclacel Pharmaceuticals, Inc. (CYCC)
Barang unggulan cyclacel.com

Quarterly revenue growth measures the percentage change in income over three months, allowing investors to differentiate a phase of aggressive business expansion from stagnation or market saturation. By analyzing the quarterly growth of commercial revenue, one can assess the effectiveness of the R&D strategy at Cyclacel Pharmaceuticals (CYCC) and the transparency of the monetization of oncology developments, which determines the long-term sustainability of the company's investment profile.

Pesaing utama

INCY - Wutah pendapatan kuartal marang kuartal|Owah-owahan pendapatan dibandhingake kuartal kepungkur HUTCHMED (HCM)|NUVB: Wutah pendapatan triwulanan|Owah-owahan pendapatan dibandhingake kuartal kepungkur Day One Bio DAWN|Wutah dodolan triwulanan MNPR|Tingkat wutah pendapatan sajrone kuartal Inhibrx Biosciences INBX|Wutah dodolan triwulanan IMAB (I-Mab Biopharma Co., Ltd.)|FENC (Fennec Pharmaceuticals Inc.) - Tambahing pendapatan triwulanan|Heron Therapeutics, Inc. - Wutah dodolan triwulanan|Owah-owahan dodolan kuartal marang kuartal NVCT (Nuvectis Pharma)|Coherus BioSciences, Inc. - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan CRBP (Corbus Pharma)|CRDF: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal beyondspringpharma.com (BYSI)|Wutah pendapatan kuartal marang kuartal bioatla.com|LIXT: Tambahing pendapatan triwulanan|Wutah pendapatan triwulanan CTXR|Wutah pendapatan triwulanan Cellectar Corp (CLRB)|Wutah pendapatan kuartal marang kuartal BioLineRx Corp BLRX|CANF (Can-Fite BioPharma Ltd.) - Dinamika pendapatan kuartal marang kuartal|APRE: Wutah dodolan triwulanan|Tingkat wutah pendapatan sajrone kuartal Kazia Therapeutics Limited|Silexion Therapeutics Corp (SLXN) - Wutah pendapatan kuartal marang kuartal|Wutah dodolan kuartal marang kuartal NCNA|CMRX (Chimerix, Inc.) - Wutah pendapatan triwulanan|Wutah dodolan triwulanan G1 Therapeutics (GTHX)|Wutah pendapatan kuartal marang kuartal Kronos Bio Corporation (KRON)|Kintara - Wutah dodolan kuartal marang kuartal|Oncternal Therapeutics, Inc. - Wutah dodolan triwulanan|Owah-owahan dodolan kuartal marang kuartal PRTG (Portage)